Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Marsh & McLennan Hits 52-Week High On Q3 Results & Deals

Published 11/21/2016, 02:52 AM
Updated 07/09/2023, 06:31 AM

On Nov 18, 2016, the stock of Marsh & McLennan Companies, Inc. (NYSE:MMC) climbed to a 52-week high of $69.43. The upside is believed to have been driven by a profitable third quarter reported last month as well as some recent announcements made by the company relating to acquisitions and an increase in share buyback.

Over the past 52-weeks, the stock has gained 25% compared with a rise of just 4.7% in the S&P 500 index over the same period.

Investors favorably viewed the company’s third-quarter results. Earnings of 69 cents per share came in line with the Zacks Consensus Estimate and increased 10% year over year. Also, revenues of $3.1 billion increased 1% year over year, led by revenue growth at both its segments – Risk and Insurance Services and Consulting.

The quality of earnings was strong as evident by an improvement in the underlying margins, despite volatility in commodity prices and foreign exchange, declining interest rates, weak global GDP growth, political instability, and lower property and casualty insurance pricing.

MARSH & MCLENNAN Price and Consensus

The stock must also have received a boost from the recent acquisition announcements. Earlier during the month, Marsh, the wholly owned subsidiary of the company inked a deal to acquire Bluefin Insurance Group Limited, a unit of AXA Group. Marsh intends to combine Bluefin and Jelf acquired last year – into a single business unit.

The latest acquisition and the subsequent integration with Jelf will enable Marsh to serve over 250,000 clients in 80 locations. The new unit is expected to become one of the leading insurance brokers for mid-size and SME companies in the U.K.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Also, last month, the company acquired Vero Insurance, Inc., renowned for its exceptional insurance products and signature personal service to high net worth individuals, families and small businesses.

The company’s inorganic growth instills investors’ confidence in the stock. Since 2009, the company has invested over $7 billion in growth and efficiency. This includes over 120 acquisitions approaching $5 billion, capital expenditures of $2.4 billion and the addition of over 10,000 colleagues. Moreover, its investments are broad based and covers geographic expansion, segmentation, and new capabilities and innovation that bode well for the long term.

Its capital management via consistent share buyback and dividend payment also must have helped it to gain investors’ favor. Earlier this month, the company announced an increase in the company’s share repurchase program to up to $2.5 billion. Also, the company’s expectation to deliver on its annual capital return commitments by reducing its share count and increasing dividend by double digits, must have worked well for the stock.
Marsh & McLennan carries a Zacks Rank #3 (Hold).

Investors may consider players like Alleghany Corp. (NYSE:Y) , Arch Capital Group Ltd. (NASDAQ:ACGL) and NMI Holdings, Inc. (NASDAQ:NMIH) . Each of these stocks carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here

Alleghany delivered positive surprises in three of the last four quarters, with an average beat of 20.52%.

Arch Capital beat expectations in each of the last four quarters, with an average beat of 9.27%.

NMI Holdings delivered positive surprises in each of the last four quarters, with an average beat of 62.8%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


MARSH &MCLENNAN (MMC): Free Stock Analysis Report

ALLEGHANY CORP (Y): Free Stock Analysis Report

ARCH CAP GP LTD (ACGL): Free Stock Analysis Report

NMI HOLDINGS-A (NMIH): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.